Endurance Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$54K Hold
1,000
0.01% 329
2023
Q1
$50K Hold
1,000
0.01% 344
2022
Q4
$46K Hold
1,000
0.01% 336
2022
Q3
$39K Sell
1,000
-250
-20% -$10K 0.01% 350
2022
Q2
$47K Hold
1,250
0.01% 331
2022
Q1
$55K Buy
1,250
+1,000
+400% +$43.3K 0.01% 341
2021
Q4
$11K Hold
250
﹤0.01% 497
2021
Q3
$11K Hold
250
﹤0.01% 510
2021
Q2
$10K Hold
250
﹤0.01% 519
2021
Q1
$10K Hold
250
﹤0.01% 530
2020
Q4
$9K Hold
250
﹤0.01% 499
2020
Q3
$10K Hold
250
﹤0.01% 468
2020
Q2
$9K Hold
250
﹤0.01% 468
2020
Q1
$8K Hold
250
﹤0.01% 444
2019
Q4
$11K Hold
250
﹤0.01% 413
2019
Q3
$10K Buy
+250
New +$10.6K ﹤0.01% 418

Other funds holding BSX

Endurance Wealth Management's BSX Position: Q2 2023 in Review

Endurance Wealth Management held its Boston Scientific (BSX) position steady in Q2 2023 at 1,000 shares worth $54K. The position accounts for 0.01% of the portfolio, ranked #329.

Endurance Wealth Management first reported a position in BSX in Q3 2019 and has held it in 16 quarters since. The position peaked at $55K in Q1 2022. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Endurance Wealth Management held 1,000 shares of Boston Scientific worth $54K as of Q2 2023.
  • Endurance Wealth Management left its Boston Scientific share count unchanged in Q2 2023.
  • Boston Scientific made up 0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #329 holding.
  • Endurance Wealth Management first reported a position in Boston Scientific in Q3 2019 and has held it in 16 quarters since.
  • Endurance Wealth Management's Boston Scientific position peaked at $55K in Q1 2022.
  • 1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.